Management of vaginal dryness and dyspareunia in estrogen sensitive cancer patients

ISSN： 1473-0766

Source： Gynecological Endocrinology, Vol.28, Iss.9, 2012-09, pp. : 740-745

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Vaginal atrophy in breast cancer survivors: role of vaginal estrogen therapy

By Mariani Luciano Gadducci Angiolo Vizza Enrico Tomao Silverio Vici Patrizia

Gynecological Endocrinology, Vol. 29, Iss. 1, 2013-01 ,pp. : 25-29

Informa Healthcare

Access to resources Recommend Favorite

Endometrial expression of the estrogen-sensitive genes MMP-26 and TIMP-4 is altered by a substitution protocol without down-regulation in IVF patients

By Pilka R. Oborna I. Lichnovsky V. Havelka P. Fingerova H. Eriksson P. Hansson S. Casslén B.

Human Reproduction, Vol. 21, Iss. 12, 2006-12 ,pp. : 3146-3156

Oxford University Press

Access to resources Recommend Favorite

Is Letrozole needed for controlled ovarian stimulation in patients with estrogen receptor-positive breast cancer?

By Revelli A. Porcu E. Levi Setti P. E. Delle Piane L. Merlo D. F. Anserini P.

Gynecological Endocrinology, Vol. 29, Iss. 11, 2013-11 ,pp. : 993-996

Informa Healthcare

Access to resources Recommend Favorite

Epidemiology and management of venous thromboembolism in patients with cancer

By Lee A.Y.Y.

Thrombosis Research, Vol. 110, Iss. 4, 2003-06 ,pp. : 167-172

Elsevier

Access to resources Recommend Favorite

Application of DNA Array Analyses in the Management of Gastrointestinal Cancer Patients

Digestive Diseases, Vol. 21, Iss. 4, 2004-02 ,pp. : 309-314

Karger

Access to resources Recommend Favorite